Literature DB >> 20854193

Pneumocystis jirovecii infection: Cell wall (1→3)-β-D-glucan biology and diagnostic utility.

Malcolm A Finkelman1.   

Abstract

Pneumocystis jirovecii has emerged as an important pulmonary pathogen. Historically associated with the immunocompromised, it is being increasingly observed in immunocompetent populations. (1→3)-ß-D-glucan (BG) is a major component of the cyst cell wall and plays an important role in the inflammatory response to the organism. Inflammatory synergy by co-stimulation with BG and Toll-like receptor ligands has been demonstrated in vitro and may be a factor in the pathophysiology of Pneumocystis pneumonia. Detection of highly elevated serum concentrations of BG in the serum of patients has been shown to be highly sensitive for the presence of pulmonary P. jirovecii.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20854193     DOI: 10.3109/1040841X.2010.484001

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  15 in total

1.  Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.

Authors:  Céline Damiani; Solène Le Gal; Cécilia Da Costa; Michèle Virmaux; Gilles Nevez; Anne Totet
Journal:  J Clin Microbiol       Date:  2013-07-31       Impact factor: 5.948

2.  (1-3)-beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients.

Authors:  F Esteves; C-H Lee; B de Sousa; R Badura; M Seringa; C Fernandes; J F Gaspar; F Antunes; O Matos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-03       Impact factor: 3.267

3.  Serum and bal beta-D-glucan for the diagnosis of Pneumocystis pneumonia in HIV positive patients.

Authors:  D Salerno; D Mushatt; L Myers; Y Zhuang; N de la Rua; E J Calderon; D A Welsh
Journal:  Respir Med       Date:  2014-11       Impact factor: 3.415

4.  Serum (1->3)-beta-D-glucan levels in primary infection and pulmonary colonization with Pneumocystis jirovecii.

Authors:  Céline Damiani; Solène Le Gal; Delphine Lejeune; Naima Brahimi; Michèle Virmaux; Gilles Nevez; Anne Totet
Journal:  J Clin Microbiol       Date:  2011-03-23       Impact factor: 5.948

Review 5.  Colonization by Pneumocystis jirovecii and its role in disease.

Authors:  Alison Morris; Karen A Norris
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

6.  Comparative Analysis of the Wako β-Glucan Test and the Fungitell Assay for Diagnosis of Candidemia and Pneumocystis jirovecii Pneumonia.

Authors:  Ricarda Friedrich; Elfriede Rappold; Christian Bogdan; Jürgen Held
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

7.  Pneumocystis jirovecii Disease: Basis for the Revised EORTC/MSGERC Invasive Fungal Disease Definitions in Individuals Without Human Immunodeficiency Virus.

Authors:  Katrien Lagrou; Sharon Chen; Henry Masur; Claudio Viscoli; Catherine F Decker; Livio Pagano; Andreas H Groll
Journal:  Clin Infect Dis       Date:  2021-03-12       Impact factor: 9.079

8.  Serological diagnosis of pneumocystosis: production of a synthetic recombinant antigen for immunodetection of Pneumocystis jirovecii.

Authors:  A L Tomás; F Cardoso; F Esteves; O Matos
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

9.  Therapeutic potential of caspofungin combined with trimethoprim-sulfamethoxazole for pneumocystis pneumonia: a pilot study in mice.

Authors:  Maria Luísa Lobo; Francisco Esteves; Bruno de Sousa; Fernando Cardoso; Melanie T Cushion; Francisco Antunes; Olga Matos
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

Review 10.  Pneumocystis Pneumonia in Solid-Organ Transplant Recipients.

Authors:  Xavier Iriart; Marine Le Bouar; Nassim Kamar; Antoine Berry
Journal:  J Fungi (Basel)       Date:  2015-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.